Chembio Diagnostics Reports First Quarter 2021 Financial Results
06 mai 2021 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
22 avr. 2021 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
01 avr. 2021 17h30 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
11 mars 2021 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors
08 mars 2021 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...
Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
25 févr. 2021 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems
14 janv. 2021 07h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the CE mark...
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
17 déc. 2020 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
02 déc. 2020 13h22 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been...
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
13 nov. 2020 16h40 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that its...